Product Code: ETC417026 | Publication Date: Oct 2022 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
The Vietnam Buprenorphine Market is projected to witness mixed growth rate patterns during 2025 to 2029. Growth accelerates to 13.69% in 2028, following an initial rate of 11.22%, before easing to 12.77% at the end of the period.
Vietnam's Buprenorphine market is anticipated to experience a high growth rate of 13.22% by 2027, reflecting trends observed in the largest economy China, followed by India, Japan, Australia and South Korea.
The Vietnam buprenorphine market plays a crucial role in addressing the country`s opioid addiction and pain management needs. Buprenorphine is a medication used to treat opioid addiction and provide pain relief. It is available in various formulations, including tablets and sublingual films. The market is driven by the efforts to combat opioid abuse and addiction, as well as the need for effective pain management options. Healthcare providers and addiction treatment centers rely on buprenorphine to support individuals in their recovery journey. The market involves both domestic and international pharmaceutical companies, all aiming to provide safe and accessible buprenorphine products.
The Vietnam buprenorphine market is growing due to its critical role in opioid addiction treatment and pain management. Buprenorphine is used as a medication-assisted treatment for opioid dependence. The increasing awareness of substance abuse issues and government initiatives to combat addiction are driving the demand for buprenorphine products. However, the market also faces challenges related to ensuring proper prescribing and monitoring to prevent misuse and diversion of the medication.
The challenge in the Vietnam buprenorphine market is to ensure responsible use for opioid addiction treatment while preventing misuse. Buprenorphine is a medication used to treat opioid dependence, and regulatory measures and healthcare education programs are needed to manage this challenge effectively.
The buprenorphine market in Vietnam may have faced challenges during the COVID-19 pandemic. Buprenorphine is used in opioid addiction treatment, and disruptions in healthcare services and restrictions on movement may have impacted access to treatment programs.
In the Vietnam Buprenorphine Market, Mundipharma stands out as a leading pharmaceutical company. Mundipharma`s commitment to providing effective and safe medications for pain management and opioid dependence treatment has made them a prominent player in this niche market.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Vietnam Buprenorphine Market Overview |
3.1 Vietnam Country Macro Economic Indicators |
3.2 Vietnam Buprenorphine Market Revenues & Volume, 2021 & 2031F |
3.3 Vietnam Buprenorphine Market - Industry Life Cycle |
3.4 Vietnam Buprenorphine Market - Porter's Five Forces |
3.5 Vietnam Buprenorphine Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.6 Vietnam Buprenorphine Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 Vietnam Buprenorphine Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Vietnam Buprenorphine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about opioid addiction and the need for treatment |
4.2.2 Rising government initiatives to address opioid abuse and dependence |
4.2.3 Growing acceptance of medication-assisted treatment (MAT) for opioid use disorder |
4.3 Market Restraints |
4.3.1 Stringent regulations and restrictions on the use of buprenorphine |
4.3.2 Limited availability of trained healthcare professionals to administer buprenorphine treatment |
4.3.3 Stigma associated with opioid addiction and MAT in Vietnamese society |
5 Vietnam Buprenorphine Market Trends |
6 Vietnam Buprenorphine Market, By Types |
6.1 Vietnam Buprenorphine Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 Vietnam Buprenorphine Market Revenues & Volume, By Application, 2021-2031F |
6.1.3 Vietnam Buprenorphine Market Revenues & Volume, By Analgesic, 2021-2031F |
6.1.4 Vietnam Buprenorphine Market Revenues & Volume, By Opioid Antagonist, 2021-2031F |
6.2 Vietnam Buprenorphine Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 Vietnam Buprenorphine Market Revenues & Volume, By Injectables, 2021-2031F |
6.2.3 Vietnam Buprenorphine Market Revenues & Volume, By Sublingual, 2021-2031F |
6.2.4 Vietnam Buprenorphine Market Revenues & Volume, By Transdermal Patches, 2021-2031F |
6.3 Vietnam Buprenorphine Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Vietnam Buprenorphine Market Revenues & Volume, By Hospital Pharmacies, 2021-2031F |
6.3.3 Vietnam Buprenorphine Market Revenues & Volume, By Retail Pharmacies, 2021-2031F |
6.3.4 Vietnam Buprenorphine Market Revenues & Volume, By Online Pharmacies, 2021-2031F |
7 Vietnam Buprenorphine Market Import-Export Trade Statistics |
7.1 Vietnam Buprenorphine Market Export to Major Countries |
7.2 Vietnam Buprenorphine Market Imports from Major Countries |
8 Vietnam Buprenorphine Market Key Performance Indicators |
8.1 Number of healthcare facilities offering buprenorphine treatment |
8.2 Patient retention rates in buprenorphine treatment programs |
8.3 Percentage of healthcare professionals trained in prescribing buprenorphine |
9 Vietnam Buprenorphine Market - Opportunity Assessment |
9.1 Vietnam Buprenorphine Market Opportunity Assessment, By Application, 2021 & 2031F |
9.2 Vietnam Buprenorphine Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 Vietnam Buprenorphine Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Vietnam Buprenorphine Market - Competitive Landscape |
10.1 Vietnam Buprenorphine Market Revenue Share, By Companies, 2024 |
10.2 Vietnam Buprenorphine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |